# EDGAR Filing Document

**Accession Number:** 0001849296
**File Stem:** 0001493152-26-005639
**Filing Date:** 2026-2
**Character Count:** 1951
**Document Hash:** e54b20acd0f90f73f2de64601d421ad7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-005639.hdr.sgml**: 20260429

**ACCESSION NUMBER**: 0001493152-26-005639

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260206

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** OKYO Pharma Ltd
- **CENTRAL INDEX KEY:** 0001849296
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 55 PARK LANE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** W1K 1NA
- **BUSINESS PHONE:** 44 (0) 207 495 2379

**MAIL ADDRESS:**
- **STREET 1:** 55 PARK LANE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** W1K 1NA

**OKYO Pharma LTD.**

Martello Court

Admiral Park

St. Peter Port

Guernsey GY1 3HB

***<u>VIA EDGAR</u>***

February 6, 2026

Securities and Exchange Commission

Division of Investment Management

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| Re: | **OKYO Pharma Ltd.** |
|  | **Registration Statement on Form F-3** |
|  | **Filed February 2, 2026** |
|  | **SEC File No. 333-293145** |

---

To Whom It May Concern:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, OKYO Pharma Ltd. (the "Registrant") hereby requests that the effective date of the above-referenced Registration Statement (the "Registration Statement") be accelerated so that the Registration Statement may become effective no earlier than 9:00 a.m., Eastern Time, on February 10, 2026, or as soon as practicable thereafter.

The Registrant requests that notification of such effectiveness be made by telephone call to Anna Tomczyk of Dechert LLP, legal counsel to the Registrant, at 212-641-5626.

Very truly yours,

**OKYO PHARMA LTD.**

---

| | |
|:---|:---|
| By: | */s/ Keeren Shah* |
| Name: | Keeren Shah |
| Title: | Chief Financial Officer |

---